Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer

NCT00421135 is registered in ClinicalTrials.gov with Alaunos Therapeutics as lead sponsor.

NCT NCT00421135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00421135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer
Lead sponsor
Alaunos Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2006
Completion date
October 31, 2007
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer